NCT00143039View on ClinicalTrials.gov

Amniotic Fluid Tandem Mass Spectrometry for Pregnancies Complicated by NIH and Severe Symmetrical IUGR

TerminatedOBSERVATIONAL
Enrollment

48

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

August 31, 2009

Study Completion Date

August 31, 2009

Conditions
Hydrops FetalisFetal Growth Retardation
Interventions
PROCEDURE

Tandem MS test for inborn errors of metabolism

Tandem MS spectrometry test will be done on all maternal blood, amniotic fluid and newborn blood samples for both groups.

Trial Locations (11)

30033

DeKalb Medical Center, Decatur

30274

Southern Regional Medical Center, Riverdale

76104

Harris Methodist Fort Worth Hospital, Fort Worth

80110

Swedish Medical Center, Denver

80218

Presbyterian/St Luke's Hospital, Denver

85006

Banner Good Sammaritan Hospital, Phoenix

85202

Banner Desert Samaritan Hospital, Phoenix

92653

Saddleback Memorial Medical Center, Laguna Hills

95124

Good Samaritan Hospital, San Jose

90801-1428

Long Beach Memorial Medical Center, Long Beach

98122-4307

Swedish Medical Center, Seattle

Sponsors
All Listed Sponsors
lead

Obstetrix Medical Group

INDUSTRY

NCT00143039 - Amniotic Fluid Tandem Mass Spectrometry for Pregnancies Complicated by NIH and Severe Symmetrical IUGR | Biotech Hunter | Biotech Hunter